ADVFN ADVFN

Hot Features

Icon for alerts 登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。
Virpax Pharmaceuticals Inc (EM)

Virpax Pharmaceuticals Inc (EM) (VRPX)

0.0004
0.00
(0.00%)
終了 6月9日 5:00AM

Virpax Pharmaceuticals Inc (EM) (VRPX) 銘柄情報

リアルタイムのディスカッションと取引のアイデア: 当社の強力なプラットフォームで自信を持って取引できます。

プレミアム

主要統計と詳細

通貨
0.0004
( - )
買値
0.00
売値
0.00
出来高
-
0.00 日の範囲 0.00
0.000001 52 週間の範囲 0.4795
時価総額
前日終値
0.0004
始値
-
時刻
最終取引時間
財務取引量
-
VWAP
-
平均取引量 (3 か月)
US$ 1,717
発行済株式数
1,062,503
配当利回り
PER
-0
1 株当たり利益 (EPS)
-70.91
歳入
-
純利益
-12.07M

Virpax Pharmaceuticals Inc (EM) について

Virpax Pharmaceuticals, Inc., a preclinical-stage pharmaceutical company, develops various drug-delivery systems and drug-releasing technologies focused on advancing non-opioid and non-addictive pain management treatments for central nervous system disorders. Its preclinical stage product candidates... Virpax Pharmaceuticals, Inc., a preclinical-stage pharmaceutical company, develops various drug-delivery systems and drug-releasing technologies focused on advancing non-opioid and non-addictive pain management treatments for central nervous system disorders. Its preclinical stage product candidates include Epoladerm, a topical spray film delivery technology for osteoarthritis pain; Probudur, an injectable local anesthetic liposomal gel technology for postoperative pain management; and Envelta, a nanotechnology-based intranasal spray drug product candidate that enables the delivery of a metabolically labile peptide drug into the brain. The company’s preclinical stage product candidates also include AnQlar, an anti-viral barrier to prevent or reduce the risk or the intensity of viral infections in humans, including influenza and SARS-CoV-2; and NobrXiol, an investigational formulation to be delivered via the nasal route to enhance cannabidiol transport to the brain. Virpax Pharmaceuticals, Inc. was founded in 2016 and is headquartered in Berwyn, Pennsylvania. 詳細を表示

セクター
Healthcare
業界
Biotechnology & Life Sciences
ウェブサイト
本社
Berwyn, United States
設立
2026
Virpax Pharmaceuticals Inc (EM) is listed in the Healthcare sector of the その他OTC with ticker VRPX. The last closing price for Virpax Pharmaceuticals (EM) was US$0. Over the last year, Virpax Pharmaceuticals (EM) shares have traded in a share price range of US$ 0.000001 to US$ 0.4795.

Virpax Pharmaceuticals (EM) currently has 1,062,503 shares in issue. The market capitalisation of Virpax Pharmaceuticals (EM) is US$425 . Virpax Pharmaceuticals (EM) has a price to earnings ratio (PE ratio) of -0.00.

VRPX 最新ニュース

表示するニュースはありません。
期間 †前日比前日比 %始値高値安値平均出来高VWAP
10.00033000.00010.00040.00015860.00028574CS
4-0.0496-99.20.050.050.000121590.00013266CS
120.000133.33333333330.00030.050.000116870.003415CS
26-0.0206-98.09523809520.0210.11.0E-624570.01660479CS
52-0.2396-99.83333333330.240.47951.0E-650780.19819316CS
156-0.1996-99.80.20.511.0E-689440.23181879CS
260-0.1996-99.80.20.511.0E-689440.23181879CS

VRPX - Frequently Asked Questions (FAQ)

What is the current Virpax Pharmaceuticals Inc (EM) share price?
The current share price of Virpax Pharmaceuticals Inc (EM) is US$ 0.0004
How many Virpax Pharmaceuticals Inc (EM) shares are in issue?
Virpax Pharmaceuticals Inc (EM) has 1,062,503 shares in issue
What is the market cap of Virpax Pharmaceuticals Inc (EM)?
The market capitalisation of Virpax Pharmaceuticals Inc (EM) is USD 425
What is the 1 year trading range for Virpax Pharmaceuticals Inc (EM) share price?
Virpax Pharmaceuticals Inc (EM) has traded in the range of US$ 0.000001 to US$ 0.4795 during the past year
What is the PE ratio of Virpax Pharmaceuticals Inc (EM)?
The price to earnings ratio of Virpax Pharmaceuticals Inc (EM) is -0
What is the registered address of Virpax Pharmaceuticals Inc (EM)?
The registered address for Virpax Pharmaceuticals Inc (EM) is 1055 Westlakes Drive, Berwyn, Pennsylvania, 19312
What is the Virpax Pharmaceuticals Inc (EM) website address?
The website address for Virpax Pharmaceuticals Inc (EM) is www.virpaxpharma.com
Which industry sector does Virpax Pharmaceuticals Inc (EM) operate in?
Virpax Pharmaceuticals Inc (EM) operates in the Biotechnology & Life Sciences sector

VRPX 取引

さらに

取引は遅延しています

リアルタイムの取引を取得するには、アカウントをアップグレードしてください

リアルタイムにアップグレード